A clinical perspective on muscle specific kinase antibody positive myasthenia gravis
The discovery of autoantibodies directed against muscle-specific kinase (MuSK) in “seronegative” myasthenia gravis (MG) patients marked a milestone in MG research. In healthy muscle, MuSK regulates a phosphorylation pathway, which is essential for the development and maintenance of acetylcholine rec...
Saved in:
| Main Authors: | Omar Keritam, Angela Vincent, Fritz Zimprich, Hakan Cetin |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2024-12-01
|
| Series: | Frontiers in Immunology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2024.1502480/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficacy and safety of rituximab in anti-MuSK myasthenia Gravis: a systematic review and meta-analysis
by: Siripong Chayanopparat, et al.
Published: (2025-02-01) -
Myasthenia Crisis as First Presentation of MuSk Positive Myasthenia Gravis: A Case Report
by: Dipesh Chhetri, et al.
Published: (2025-02-01) -
Myasthenia gravis in clinical practice
by: Eduardo de Paula Estephan, et al.
Published: (2022-08-01) -
IMMUNOPATHOGENESIS OF MYASTHENIA GRAVIS (REVIEW)
by: E. D. Gasymly
Published: (2018-06-01) -
New acute onset of ocular myasthenia gravis after COVID-19 vaccine: A case report
by: Himani T. Chaturvedi, et al.
Published: (2023-02-01)